MedTrace Logo

A Professional Development Programme (ProDeveloP) for Newly Graduated Nurses

NCT06742047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2026-03-18

Study results available
· View outcomes & findings →

Summary

This clinical study aims to implement and evaluate a professional development programme (ProDeveloP) designed to facilitate the transition of newly graduated nurses (NGNs) into their new roles. NGNs face several challenges in the work environment and in developing their professional competencies. The aim is to support NGNs in a county hospital in central Sweden to facilitate their professional development. Data will be collected during the NGNs' first year through measures at week week 13 (for both arms) and quarterly (intervention grpoup). This will be combined with individual interviews and focus groups with NGNs, dialogue facilitators and managers.

Conditions

  • Nurse Role
  • Professional Fulfillment
  • Professional Identity Formation
  • Professional Quality of Life
  • Support Program
  • Development

Interventions

BEHAVIORAL

Professional development programme

The professional development programme include dialogue groups facilitated by registered nurses (RN) who are expert and experienced supervisors that received a three day training before conducting the groups. Then including education days with joint lectures and simulations with experts in the field with experience. The programme provides NGNs with regular opportunities for reflection for learning from experiences of care to enhance personal and professional growth.

Sponsors & Collaborators

  • Region Västmanland

    collaborator OTHER

  • AFA Insurance

    collaborator INDUSTRY

  • Mälardalen University

    lead OTHER

Principal Investigators

  • Margareta Asp, Professor · Mälardalens University

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-27
Primary Completion
2024-09-17
Completion
2025-10-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06742047 on ClinicalTrials.gov